Insufficient scRNA-seq data for expression of TNN at single-cell level.
Insufficient scRNA-seq data for expression of TNN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 1226.31 | 454 / 459 | 81% | 8.53 | 904 / 1118 |
thymus | 90% | 315.60 | 585 / 653 | 31% | 1.20 | 188 / 605 |
adipose | 96% | 604.10 | 1160 / 1204 | 0% | 0 | 0 / 0 |
liver | 71% | 85.48 | 160 / 226 | 22% | 0.53 | 91 / 406 |
spleen | 76% | 96.57 | 183 / 241 | 0% | 0 | 0 / 0 |
skin | 58% | 350.77 | 1052 / 1809 | 14% | 1.10 | 64 / 472 |
lung | 44% | 53.74 | 253 / 578 | 18% | 0.64 | 212 / 1155 |
brain | 5% | 3.45 | 127 / 2642 | 49% | 1.34 | 348 / 705 |
pancreas | 3% | 2.31 | 9 / 328 | 51% | 1.58 | 91 / 178 |
stomach | 28% | 39.90 | 100 / 359 | 24% | 1.34 | 70 / 286 |
intestine | 40% | 61.89 | 382 / 966 | 11% | 0.31 | 60 / 527 |
kidney | 24% | 23.69 | 21 / 89 | 22% | 0.64 | 197 / 901 |
esophagus | 23% | 19.28 | 335 / 1445 | 18% | 0.87 | 33 / 183 |
heart | 28% | 32.19 | 239 / 861 | 0% | 0 | 0 / 0 |
uterus | 4% | 8.73 | 7 / 170 | 19% | 1.32 | 87 / 459 |
prostate | 5% | 6.42 | 13 / 245 | 14% | 0.33 | 68 / 502 |
bladder | 5% | 2.67 | 1 / 21 | 12% | 1.10 | 61 / 504 |
adrenal gland | 10% | 9.28 | 26 / 258 | 5% | 0.11 | 11 / 230 |
tonsil | 0% | 0 | 0 / 0 | 13% | 0.21 | 6 / 45 |
peripheral blood | 12% | 21.53 | 115 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 8% | 9.36 | 103 / 1335 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 6% | 0.15 | 27 / 430 |
eye | 0% | 0 | 0 / 0 | 3% | 0.06 | 2 / 80 |
muscle | 1% | 1.07 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0033689 | Biological process | negative regulation of osteoblast proliferation |
GO_0007160 | Biological process | cell-matrix adhesion |
GO_1903672 | Biological process | positive regulation of sprouting angiogenesis |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0007409 | Biological process | axonogenesis |
GO_0030334 | Biological process | regulation of cell migration |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_1905899 | Biological process | regulation of smooth muscle tissue development |
GO_1903010 | Biological process | regulation of bone development |
GO_1990138 | Biological process | neuron projection extension |
GO_0030155 | Biological process | regulation of cell adhesion |
GO_0002076 | Biological process | osteoblast development |
GO_0070593 | Biological process | dendrite self-avoidance |
GO_2001223 | Biological process | negative regulation of neuron migration |
GO_0005615 | Cellular component | extracellular space |
GO_1990026 | Cellular component | hippocampal mossy fiber expansion |
GO_0043025 | Cellular component | neuronal cell body |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0009986 | Cellular component | cell surface |
GO_0097442 | Cellular component | CA3 pyramidal cell dendrite |
GO_0090733 | Cellular component | tenascin complex |
GO_0042802 | Molecular function | identical protein binding |
GO_0005178 | Molecular function | integrin binding |
Gene name | TNN |
Protein name | Tenascin-N (TN-N) (Tenascin-W) (TN-W) Tenascin N |
Synonyms | TNW |
Description | FUNCTION: Extracellular matrix protein that seems to be a ligand for ITGA8:ITGB1, ITGAV:ITGB1 and ITGA4:ITGB1 (By similarity) . Involved in neurite outgrowth and cell migration in hippocampal explants (By similarity). During endochondral bone formation, inhibits proliferation and differentiation of proteoblasts mediated by canonical WNT signaling (By similarity). In tumors, stimulates angiogenesis by elongation, migration and sprouting of endothelial cells . Expressed in most mammary tumors, may facilitate tumorigenesis by supporting the migratory behavior of breast cancer cells . . |
Accessions | ENST00000621086.1 Q9UQP3 A0A087WXC4 ENST00000239462.9 |